Clinical Trial Update: Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial to evaluate preoperative chemoradiotherapy combined with toripalimab for locally recurrent rectal cancer; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Recurrent Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING